BFC
ONC icon

Bedel Financial Consulting’s BeOne Medicines Ltd ONC Stock Holding History

Bedel Financial Consulting’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-350
Closed -$66K – 955
2022
Q1 		$66K Hold
350
– – 0.02% 349
2021
Q4 		$95K Hold
350
– – 0.03% 294
2021
Q3 		$127K Hold
350
– – 0.04% 234
2021
Q2 		$120K Hold
350
– – 0.04% 241
2021
Q1 		$122K Buy
+350
New +$116K 0.05% 234

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Bedel Financial Consulting's ONC Position: Q2 2022 in Review

Bedel Financial Consulting sold out of BeOne Medicines Ltd (ONC) in Q2 2022, closing a stake of 350 shares — an estimated $66K sold.

Bedel Financial Consulting first reported a position in ONC in Q1 2021 and held it in 5 quarters. The position peaked at $127K in Q3 2021. 235 funds tracked by Wall St. Rank hold ONC as of Q2 2022.

  • Bedel Financial Consulting reported no remaining BeOne Medicines Ltd position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 350 BeOne Medicines Ltd shares in Q2 2022, an estimated $66K.
  • Bedel Financial Consulting first reported a position in BeOne Medicines Ltd in Q1 2021 and held it in 5 quarters.
  • Bedel Financial Consulting's BeOne Medicines Ltd position peaked at $127K in Q3 2021.
  • 235 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.